Abstract

The incidence of Alzheimer’s disease (AD) is increasing day by day worldwide, which results in a poor quality of life. Early diagnosis and treatment of AD is necessary to suppress the progression of the disease. Conventional treatments have several limitations due to the protective blood-brain barrier.

Keywords

alzheimer’s disease, beta-amyloid, aggregation, theranostics, nanomedicine